Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Change in Receivables (2021 - 2022)

P3 Health Partners (PIII) has disclosed Change in Receivables for 2 consecutive years, with $1.2 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Change in Receivables rose 3191.11% year-over-year to $1.2 million, compared with a TTM value of $3.2 million through Sep 2022, changed N/A, and an annual FY2021 reading of $1.5 million, changed N/A over the prior year.
  • Change in Receivables was $1.2 million for Q3 2022 at P3 Health Partners, up from $1.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.5 million in Q4 2021 and bottomed at -$805178.0 in Q1 2022.